The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
A lire aussi
Cancer therapeutics: evaluation and clinical transfer of (nano)-compounds - 2021, April 23rd
07 April 2021
par Isabelle Frapart
J.-M. Bonmatin co-author of an article in One Health (18 March 2021)
07 April 2021
par Isabelle Frapart
Webconference “Les vaccins à ARN, vers une nouvelle ère de la vaccination” - March 29, 2021
18 March 2021
par Isabelle Frapart